The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ANAPTYSBIO INC | COM | 032724106 | 3,803 | 176,894 | SH | DFND | 0 | 176,894 | 0 | ||
BIGCOMMERCE HLDGS INC | COM SER 1 | 08975P108 | 1,546 | 24,094 | SH | DFND | 0 | 24,094 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 213 | 15,234 | SH | DFND | 0 | 15,234 | 0 | ||
NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 47,665 | 1,573,357 | SH | DFND | 1,573,357 | 0 | 0 | ||
PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 11,990 | 360,939 | SH | DFND | 360,939 | 0 | 0 | ||
PROGYNY INC | COM | 74340E103 | 57 | 1,338 | SH | DFND | 0 | 1,338 | 0 | ||
THE REALREAL INC | COM | 88339P101 | 11,737 | 600,664 | SH | DFND | 600,664 | 0 | 0 |